Holen Sie sich die Stockscreener-App
10.33
5.92%
-0.65
Handel nachbörslich:
10.48
0.15
+1.45%
Schlusskurs vom Vortag:
$10.98
Offen:
$10.8
24-Stunden-Volumen:
1.08M
Relative Volume:
2.19
Marktkapitalisierung:
$484.41M
Einnahmen:
$502.79M
Nettoeinkommen (Verlust:
$23.71M
KGV:
20.66
EPS:
0.5
Netto-Cashflow:
$6.35M
1W Leistung:
-14.91%
1M Leistung:
-16.02%
6M Leistung:
-13.12%
1J Leistung:
-45.86%
1-Tages-Spanne:
$10.31
$10.95
1-Wochen-Bereich:
$10.31
$12.51
52-Wochen-Spanne:
$9.72
$21.83
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Vergleichen Sie CLB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
10.33 | 514.89M | 502.79M | 23.71M | 6.35M | 0.50 |
|
SLB
Slb Ltd
|
31.72 | 49.49B | 35.49B | 4.21B | 4.61B | 2.9191 |
|
BKR
Baker Hughes Company
|
45.04 | 47.21B | 27.61B | 3.08B | 2.17B | 3.0568 |
|
TS
Tenaris S A Adr
|
33.69 | 18.47B | 11.79B | 2.04B | 1.91B | 3.6876 |
|
HAL
Halliburton Co
|
21.97 | 19.95B | 22.56B | 2.10B | 2.34B | 2.39 |
|
FTI
Technipfmc Plc
|
35.79 | 15.17B | 9.51B | 919.70M | 1.32B | 2.12 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Why Core Laboratories Inc. stock appeals to dividend investorsBond Market & Comprehensive Market Scan Insights - newser.com
What’s the recovery path for long term holders of Core Laboratories Inc.Price Action & Advanced Swing Trade Entry Plans - newser.com
How cyclical is Core Laboratories Inc. stock compared to rivalsJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
Core Laboratories (NYSE:CLB) Given Sell (D+) Rating at Weiss Ratings - MarketBeat
Can Core Laboratories Inc. stock double in coming yearsPortfolio Value Report & Accurate Trade Setup Notifications - newser.com
How Core Laboratories Inc. stock reacts to inflationary pressures2025 Top Decliners & Intraday High Probability Alerts - newser.com
Farther Finance Advisors LLC Lowers Stock Holdings in Core Laboratories Inc. $CLB - Defense World
Analyzing net buyer seller activity in Core Laboratories Inc.Trade Analysis Report & Momentum Based Trading Ideas - newser.com
Zacks Industry Outlook Highlights TechnipFMC, Archrock Inc and Core Laboratories - Zacks Investment Research
Here's Why Holding Core Laboratories Stock Is Justified for Now - Zacks Investment Research
Can momentum traders help lift Core Laboratories Inc.July 2025 Catalysts & Fast Exit Strategy with Risk Control - newser.com
What drives HIMX stock priceMarket Sentiment Indicators & Superior Capital Trading - earlytimes.in
What analysts say about Core Laboratories Inc stockAutomated Trading Signals & Rapid Portfolio Investment - earlytimes.in
Exchange Capital Management Inc. Sells 38,138 Shares of Core Laboratories Inc. $CLB - MarketBeat
Can Core Laboratories Inc. stock rebound after recent weaknessJuly 2025 Closing Moves & Consistent Income Trade Ideas - newser.com
Best data tools to analyze Core Laboratories Inc. stockGlobal Markets & Daily Technical Forecast Reports - newser.com
CORE LABORATORIES ANNOUNCES STRATEGIC ACQUISITION OF BRAZIL-BASED SOLINTEC - Sahm
Core Laboratories announces strategic acquisition of Brazil-based Solintec - MarketScreener
Core Laboratories (CLB) Acquires Leading Brazilian Geological Se - GuruFocus
Core Laboratories acquires Brazil-based Solintec to expand presence By Investing.com - Investing.com Canada
Major Oil Services Expansion: Core Labs Acquires Brazil's Leading Geological Lab Solintec for Pre-Salt Analysis - Stock Titan
Core Laboratories announced acquisition of Brazil-based integrated geological services co, Solintec - MarketScreener
Core Laboratories : Lab Solintec Aquisition Press Release - MarketScreener
Here is Why Core Laboratories (CLB) Fell This Week - MSN
Core Laboratories (NYSE:CLB) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Core Laboratories (NYSE:CLB) Stock Price Crosses Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Financial Survey: Core Laboratories (NYSE:CLB) versus Caspian Services (OTCMKTS:CSSV) - Defense World
Core Laboratories Stock Rebounds in a Month: Is it Time to Buy? - Zacks Investment Research
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):